Intercept Pharmaceuticals Downgraded

By: via Benzinga
Bank of America downgraded Intercept Pharmaceuticals Inc (NASDAQ: ICPT) Tuesday from Buy to Neutral and maintained a $315 price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.